Search

Your search keyword '"A Philis-Tsimikas"' showing total 29 results
Start Over Author "A Philis-Tsimikas" Journal canadian journal of diabetes
29 results on '"A Philis-Tsimikas"'

5. Improved Glycemic Control with Carbohydrate Counting for Adjustment of Fast-Acting Insulin Aspart vs. Insulin Aspart in Subjects with Type 1 Diabetes

Author

Marek Demissie, Kristine Buchholtz, Athena Philis-Tsimikas, Bruce W. Bode, Ludger Rose, Edward Franek, Thomas R. Pieber, and Rémi Rabasa-Lhoret

Subjects
Type 1 diabetes, medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, General Medicine, medicine.disease, Insulin aspart, Carbohydrate counting, Endocrinology, Internal medicine, Internal Medicine, medicine, business, Glycemic, medicine.drug
Published
2018

6. Within-day Variability Based on 9-point Profiles Associates with Overall and Nocturnal Hypoglycemia Risk in Adults with Type 1 (T1D) or Type 2 Diabetes (T2D)

Author

Bailey, Timothy, primary, Bhargava, Anuj, additional, Devries, J. Hans, additional, Gerety, Gregg, additional, Gumprecht, Janusz, additional, Lane, Wendy, additional, Wysham, Carol, additional, Bak, Britta A., additional, Hansen, Charlotte T., additional, Chandarana, Keval, additional, and Philis-Tsimikas, Athena, additional

Published
2017
Full Text
View/download PDF

7. Day-to-day Variability of Fasting Self-Measured Blood Glucose (SMBG) Associates with Hypoglycemia Risk in Adults with Type 1 (T1D) or Type 2 Diabetes (T2D)

Author

Bailey, Timothy S., primary, Bhargava, Anuj, additional, Devries, J. Hans, additional, Gerety, Gregg, additional, Gumprecht, Janusz, additional, Lane, Wendy, additional, Wysham, Carol, additional, Bak, Britta A., additional, Hachmann-Nielsen, Elise, additional, Chandarana, Keval, additional, and Philis-Tsimikas, Athena, additional

Published
2017
Full Text
View/download PDF

9. Within-day Variability Based on 9-point Profiles Associates with Overall and Nocturnal Hypoglycemia Risk in Adults with Type 1 (T1D) or Type 2 Diabetes (T2D)

Author

Janusz Gumprecht, Gregg Gerety, Anuj Bhargava, Timothy L. Bailey, Carol Wysham, Charlotte T. Hansen, Athena Philis-Tsimikas, Britta A. Bak, Keval Chandarana, J. Hans DeVries, and Wendy Lane

Subjects
medicine.medical_specialty, Pediatrics, business.industry, Endocrinology, Diabetes and Metabolism, General Medicine, Type 2 diabetes, medicine.disease, Nocturnal hypoglycemia, Endocrinology, Internal medicine, Internal Medicine, medicine, business
Published
2017

10. Day-to-day Variability of Fasting Self-Measured Blood Glucose (SMBG) Associates with Hypoglycemia Risk in Adults with Type 1 (T1D) or Type 2 Diabetes (T2D)

Author

Carol Wysham, Timothy S. Bailey, Wendy Lane, Athena Philis-Tsimikas, Elise Hachmann-Nielsen, Britta A. Bak, Anuj Bhargava, J. Hans DeVries, Gregg Gerety, Janusz Gumprecht, and Keval Chandarana

Subjects
Pediatrics, medicine.medical_specialty, Endocrinology, business.industry, Endocrinology, Diabetes and Metabolism, Internal Medicine, medicine, General Medicine, Type 2 diabetes, Hypoglycemia, Day to day, medicine.disease, business
Published
2017

13. Double-Blind Mealtime Faster-Acting Insulin Aspart vs. Insulin Aspart in Basal-Bolus Improves Glycemic Control in T1D: The Onset® 1 Trial

Author

Russell-Jones, David, primary, Bode, Bruce W., additional, Block, Christophe De, additional, Franek, Edward, additional, Heller, Simon, additional, Mathieu, Chantal, additional, Philis-Tsimikas, Athena, additional, Rose, Ludger, additional, Woo, Vincent, additional, Birk Østerskov, Anne, additional, Graungaard, Tina, additional, Pakseresht, Arash, additional, and Bergenstal, Richard, additional

Published
2016
Full Text
View/download PDF

15. Achieving FPG Target Without Hypoglycemia: A Meta-Analysis of Insulin Degludec vs. Insulin Glargine U100

Author

Rajeev Jain, Chantal Mathieu, Luigi F. Meneghini, Deniz Tutkunkardas, Lars Bardtrum, Bernard Zinman, Athena Philis-Tsimikas, Stephen L. Atkin, and Jina Hahn

Subjects
Insulin degludec, medicine.medical_specialty, Insulin glargine, business.industry, Endocrinology, Diabetes and Metabolism, General Medicine, Hypoglycemia, medicine.disease, Endocrinology, Meta-analysis, Internal medicine, Internal Medicine, medicine, business, medicine.drug
Published
2016

16. Double-Blind Mealtime Faster-Acting Insulin Aspart vs. Insulin Aspart in Basal-Bolus Improves Glycemic Control in T1D: The Onset® 1 Trial

Author

Vincent Woo, Richard M. Bergenstal, Bruce W. Bode, Tina Graungaard, Athena Philis-Tsimikas, Simon Heller, Christophe De Block, David Russell-Jones, Edward Franek, Arash Pakseresht, Chantal Mathieu, Ludger Rose, and Anne Birk Østerskov

Subjects
business.industry, Endocrinology, Diabetes and Metabolism, Basal bolus, 030209 endocrinology & metabolism, General Medicine, Double blind, Insulin aspart, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Anesthesia, Internal Medicine, Medicine, 030212 general & internal medicine, business, Glycemic, medicine.drug
Published
2016

17. Meta-Analysis Comparing Hypoglycemia Rates of Insulin Degludec with Insulin Glargine U100 Across Clinical Trials with up to 2 Years' Duration

Author

Bernard Zinman, Athena Philis-Tsimikas, Jina Hahn, Stefano Del Prato, Michiel Cvan Leeuwen, Lone Nørgård Troelsen, Bruce W. Bode, and Chantal Mathieu

Subjects
Insulin degludec, medicine.medical_specialty, Insulin glargine, business.industry, Endocrinology, Diabetes and Metabolism, General Medicine, Hypoglycemia, medicine.disease, Clinical trial, Endocrinology, Internal medicine, Meta-analysis, Internal Medicine, medicine, Duration (project management), business, medicine.drug
Published
2016

25. Reduced Risk of Hypoglycemia with Insulin Degludec vs. Insulin Glargine in Patients with Type 2 Diabetes and a BMI >30 kg/m2: A Meta-analysis of 5 Randomized Trials

Author

Rahul Kapur, Helena W. Rodbard, Lars Endahl, Luigi F. Meneghini, David Russell-Jones, Athena Philis-Tsimikas, and Jovana Kapor

Subjects
Insulin degludec, Reduced risk, medicine.medical_specialty, Insulin glargine, business.industry, Endocrinology, Diabetes and Metabolism, General Medicine, Type 2 diabetes, Hypoglycemia, medicine.disease, law.invention, Endocrinology, Randomized controlled trial, law, Internal medicine, Meta-analysis, Internal Medicine, medicine, In patient, business, medicine.drug
Published
2013

28. The Effect of Insulin Degludec on Glycemic Control and Nocturnal Hypoglycemia Compared with Insulin Glargine: a 1-year Randomized Trial in Insulin-naïve People with Type 2 Diabetes

Author

Thue Johansen, Bernard Zinman, Chantal Mathieu, Azhar Rana, Yehuda Handelsman, Bertrand Cariou, Helena W. Rodbard, and Athena Philis-Tsimikas

Subjects
Insulin degludec, medicine.medical_specialty, Insulin glargine, business.industry, Endocrinology, Diabetes and Metabolism, General Medicine, Type 2 diabetes, Hypoglycemia, medicine.disease, Lower risk, Gastroenterology, Insulin aspart, Endocrinology, Internal medicine, Diabetes mellitus, Internal Medicine, medicine, business, medicine.drug, Glycemic
Abstract

s / Can J Diabetes 36 (2012) S24eS76 S58 The study comprised a 1-yr main period followed by 1-yr extension; subjects maintained prior randomization. Subjects were randomized 3:1 to IDeg or IGlar given subcutaneously once daily with mealtime insulin aspart. Basal insulin was titrated to target pre-breakfast plasma glucose (PG) (>3.9e

Published
2012

29. Insulin Degludec is Superior to Sitagliptin in Improving Glycemic Control in Insulin-naïve Patients with Type 2 Diabetes

Author

Søren Rasmussen, Anuj Bhargava, Athena Philis-Tsimikas, Mala Dharmalingam, Azhar Rana, Stefano Del Prato, Ilhan Satman, Alan J. Garber, and Vincent Woo

Subjects
Insulin degludec, medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, General Medicine, Type 2 diabetes, Insulin naive, medicine.disease, Endocrinology, Sitagliptin, Internal medicine, Internal Medicine, medicine, business, Glycemic, medicine.drug
Published
2012

Catalog

Books, media, physical & digital resources
See catalog results